Rushikesh's Updates (35)
-
-
-
According to research from SNS Insider, the Medical Coding Market reached a value of US$ 20.83 Billion in 2022 and is expected to grow to US$ 48.35 Billion by 2030, exhibiting a robust CAGR of 11.1% during the forecast period spanning from 2023 to 2030. Read more : https://www.yahoo.com/lifestyle/medical-coding-market-size-estimated-150000954.html [more]
-
-
SNS Insider's research division has introduced a fresh market study on the "Medical Coding Market". This latest addition to their research database provides insights into the market's size, share, and segmentation. It delves into various aspects including classification systems, components, end-users, and regional dynamics. The report offers a comprehensive forecast spanning from 2023 to 2030, equipping stakeholders with valuable information to navigate the evolving landscape of... [more]
-
-
SNS Insider has recently updated its research database with a cutting-edge market study on the "Internet of Things in Healthcare Market". This comprehensive analysis encompasses crucial aspects such as market size, share, and segmentation. It covers various components, applications, connectivity technologies, end-uses, and regional dynamics. The report offers insights into the evolving landscape of IoT in healthcare, providing stakeholders with valuable information to navigate this... [more]
-
-
SNS Insider has recently incorporated a fresh market report study focusing on the "Time and Attendance Software Market". This comprehensive study delves into aspects such as market size, share, and segmentation. It covers key components including software and services, deployment types such as on-cloud and on-premises, organization sizes ranging from small to large, and various industry verticals like BFSI, IT, Manufacturing, Government, and others. Additionally, the report provides... [more]
-
-
The Liver Biopsy Market, valued at USD 5505.71 million in 2023, is projected to reach USD 9249.79 million by 2031, with a 6.7% CAGR from 2024 to 2031. This growth is driven by increasing liver disease incidences, necessitating accurate diagnostic procedures. Advancements in imaging and biopsy techniques enhance safety and efficiency, while rising awareness and healthcare infrastructure expansion fuel market expansion. Read more :https://www.snsinsider.com/reports/liver-biopsy-market-2796 [more]
-
-
The Contraceptives Market surged from USD 1.30 billion in 2023 to a projected USD 6.10 billion by 2031, boasting a 21.20% CAGR from 2024 to 2031. This growth is driven by rising global awareness of family planning, advancements in contraceptive tech, and increased access in developing regions. Innovative options like LARCs and hormonal implants fuel market expansion, shaping population dynamics and public health.Read more :
[more] -
-
The Microbiome Therapeutics Market has witnessed substantial growth, starting at USD 115.2 million in 2023 and forecasted to surge to USD 1403.14 million by 2031, boasting a remarkable CAGR of 40.16% from 2024 to 2031. This surge is attributed to the increasing understanding of the human microbiome's role in health and disease, driving the development of microbiome-based therapeutics. These therapies offer novel approaches to treat various diseases by targeting the gut microbiota, offering... [more]
-
-
The Angio Suites Market has displayed remarkable growth, reaching USD 1245.0 million in 2022, and is forecasted to surge to USD 2104.20 million by 2030, with a steady CAGR of 6.78% from 2023 to 2030. This growth is propelled by increasing prevalence of cardiovascular diseases and the subsequent rise in demand for minimally invasive procedures. Angio suites provide advanced imaging capabilities essential for precise diagnosis and treatment planning, driving their adoption in hospitals and... [more]
-
-
The Needle-Free Injector Market is experiencing significant growth, valued at USD 1.87 billion in 2023 and projected to escalate to USD 3.37 billion by 2031, marking a robust CAGR of 7.59% from 2024 to 2031. This surge is fueled by the increasing adoption of needle-free injection systems across various healthcare settings globally. These innovative devices offer painless drug delivery, reduce the risk of needlestick injuries, and improve patient compliance, driving their demand. Moreover,... [more]
-
-
The Brain Tumor Drugs Market has emerged as a pivotal segment within the pharmaceutical industry, estimated at US$ 2.9 billion in 2022. Projections paint a promising picture, with anticipated growth to US$ 5.73 billion by 2030, showcasing a notable compound annual growth rate (CAGR) of 8.9% over the forecast period spanning from 2022 to 2030. This forecasted expansion underscores the pressing need for innovative therapeutics in combating brain tumors, one of the most challenging medical... [more]
-
-
The Medical Tourism Market has emerged as a dynamic force in the global healthcare industry, boasting a valuation of USD 12.16 billion in 2023. Projections point towards a meteoric rise, with expectations set to soar to USD 74.37 billion by 2031, underpinned by an impressive compound annual growth rate (CAGR) of 25.40% over the forecast period from 2024 to 2031. This exponential growth is fueled by several factors, including increasing healthcare costs in developed countries, advancements in... [more]
-
-
The Magnetic Resonance Imaging (MRI) Market has solidified its position as a cornerstone of modern medical diagnostics, commanding a valuation of USD 6.6 billion in 2023. Projections indicate a robust trajectory, with expectations soaring to USD 11 billion by 2031, underpinned by a steady compound annual growth rate (CAGR) of 6.6% over the forecasted period from 2024 to 2031. This anticipated growth underscores the indispensable role of MRI technology in diagnosing a wide array of medical... [more]
-
-
The Sleep Apnea Devices Market has emerged as a significant player in the healthcare landscape, boasting a valuation of USD 4.69 billion in 2023. With projections pointing towards continued growth, the market is anticipated to escalate to USD 7.82 billion by 2031, fueled by a robust compound annual growth rate (CAGR) of 6.60% over the forecast period spanning from 2024 to 2031. This upward trajectory underscores the rising prevalence of sleep disorders globally and the increasing recognition... [more]
-
-
The Over-The-Counter (OTC) drugs market showcased remarkable growth, attaining a valuation of USD 175.6 billion in 2023. Projections indicate a continued upward trajectory, with expectations soaring to USD 275.7 billion by 2031. This surge reflects a robust compound annual growth rate (CAGR) of 5.80% throughout the forecast period spanning from 2024 to 2031. Such a buoyant market performance underscores the increasing reliance on self-medication and the accessibility of OTC remedies. Factors... [more]
Copyright 2019 © P-tweets Refunds